MFDS
- Status: likely_approved
🇰🇷 Xtoro in South Korea
Xtoro (FINAFLOXACIN) regulatory status in South Korea.
Marketing authorisation
Xtoro in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in South Korea
Frequently asked questions
Is Xtoro approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Xtoro in South Korea?
Fonseca Biosciences is the originator. The local marketing authorisation holder may differ — check the official source linked above.